Inventor · disambiguated record
David Bryant Batt
Also filed as: BATT DAVID B · BATT DAVID BRYANT
4 granted patents·8 pending applications·345 citations·filing 1993–2018
81Inventor score
Top patents by PatentIndex Score
12 records- 0190US5908779ATargeted RNA degradation using nuclear antisense RNAUNIV CONNECTICUT·Filed 1993·Granted Jun 1, 1999·278 cites·13 claims
- 0286US9415118B2Antibody drug conjugatesBATT JULIE LYNN·Filed 2014·Granted Aug 16, 2016·9 cites·24 claims
- 0379US9498532B2Antibody drug conjugatesBATT DAVID BRYANT·Filed 2014·Granted Nov 22, 2016·8 cites·32 claims
- 0477US6265167B1Targeted RNA degradation using nuclear ribozyme RNAFiled 1999·Granted Jul 24, 2001·50 cites·20 claims
- 0552US2017008964A1Antibody drug conjugatesBATT DAVID BRYANT·Filed 2016·Application pending·0 cites
- 0650US2006252041A1PCR-based diagnostic method of detecting a mutation in the b-raf geneBATT DAVID B·Filed 2003·Application pending·0 cites
- 0750US2019345250A1Antibody drug conjugatesBATT DAVID BRYANT·Filed 2018·Application pending·0 cites
- 0848US2009069360A1Organic CompoundsBATT DAVID BRYANT·Filed 2007·Application pending·0 cites
- 0945US2007060582A11,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseasesFINK CYNTHIA A·Filed 2004·Application pending·0 cites
- 1043US2006293340A12-Aminopyrimidine derivatives as raf kinase inhibitorsNOVARTIS AG·Filed 2004·Application pending·0 cites
- 1142US2007099250A1Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseasesHU PING·Filed 2004·Application pending·0 cites
- 1238US2017106095A1Antibody drug conjugatesBATT DAVID BRYANT·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Bryant Batt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →